Collection of Blood for Gene Expression/Genomic Studies in Individuals With Diabetes (Qatar)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01172743|
Recruitment Status : Suspended (Closed Administratively)
First Posted : July 30, 2010
Last Update Posted : May 24, 2017
|Condition or disease|
|Diabetes Mellitus Type 2 Diabetes Mellitus|
|Study Type :||Observational|
|Estimated Enrollment :||500 participants|
|Official Title:||Collection of Blood for Gene Expression/Genomic Studies in Individuals With Diabetes (Qatar)|
|Study Start Date :||June 2009|
|Estimated Primary Completion Date :||December 2020|
|Estimated Study Completion Date :||December 2020|
Individuals with diabetes that fit eligibility criteria.
Individuals without history of diabetes.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01172743
|Hamad Medical Corporation|
|Study Director:||Ronald G Crystal, MD||Weill Cornell Medical College, NY and Qatar|